CAIRE closes MGC acquisition
By HME News Staff
Updated 9:25 AM CST, Thu January 5, 2023
BALL GROUND, Ga. - CAIRE has finalized the acquisition of St. Paul, Minn.-based MGC Diagnostics Holdings, Inc. (MGC), a maker of non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease. “This acquisition provides the means of serving the patient in a more holistic way — improving their quality of care throughout their entire journey,” said Earl Lawson, CAIRE president and CEO. “With MGC, we address the needs of patients early in the progression of pulmonary disease with a proven portfolio of equipment that addresses awareness and diagnostic tools for the health care provider and clinician.” Brookwood Associates acted as the financial advisor to CAIRE in the acquisition, which the company first announced in November.
Comments